- Published: Thursday, May 28, 2015 07:06 PM
SPRINGFIELD – Today, legislation sponsored by State Senator Tony Munoz (D-Chicago) that would allow pharmacists to substitute a prescription for a biological product with a biosimilar product was approved by the Senate.
A biologic is an original medical product that is manufactured by an innovator. A biosimilar is an approved version of that product that can be made available after the original product patent expires. As with name-brand prescriptions and generics, pricing for the latter is usually more affordable.